Literature DB >> 14740114

["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].

M Ptok1, R Schönweiler, T Nawka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14740114     DOI: 10.1007/s00106-003-1008-6

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  12 in total

1.  Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).

Authors:  M F Brin; A Blitzer; S Fahn; W Gould; R E Lovelace
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

2.  Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.

Authors:  M F Brin; A Blitzer; C Stewart
Journal:  Adv Neurol       Date:  1998

3.  Recurrent laryngeal nerve section for spastic dysphonia.

Authors:  H H Dedo
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Jul-Aug       Impact factor: 1.547

4.  Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).

Authors:  A Blitzer; M F Brin; S Fahn; R E Lovelace
Journal:  Laryngoscope       Date:  1988-02       Impact factor: 3.325

5.  Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.

Authors:  N D Hogikyan; W P Wodchis; C Spak; P R Kileny
Journal:  J Voice       Date:  2001-12       Impact factor: 2.009

Review 6.  Botulinum toxin: basic science and clinical uses in otolaryngology.

Authors:  A Blitzer; L Sulica
Journal:  Laryngoscope       Date:  2001-02       Impact factor: 3.325

7.  Botulinum toxin for the treatment of spasmodic dysphonia.

Authors:  S R Gibbs; A Blitzer
Journal:  Otolaryngol Clin North Am       Date:  2000-08       Impact factor: 3.346

8.  Vocal mechanics as the basis for phonosurgery.

Authors:  N Isshiki
Journal:  Laryngoscope       Date:  1998-12       Impact factor: 3.325

9.  Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.

Authors:  A Blitzer; M F Brin; C F Stewart
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

10.  Laryngeal dystonia: a series with botulinum toxin therapy.

Authors:  A Blitzer; M F Brin
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-02       Impact factor: 1.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.